IndiaTickerCertificate under SEBI (Depositories and Participants) Regulations, 2018 - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Company dossier
Valiant Laboratories
NSE:VALIANTLAB · ISIN INE0JWS01017
- Close
- ₹61.74 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Valiant Laboratories
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Valiant Laboratories Ltd - 543998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Closure of Trading WindowBSE · financial results · pdf
Source filing Reply to Clarification- Financial results - Valiant Laboratories LimitedNSE · financial results · pdf
Source filing Reply to Clarification- Financial results - Valiant Laboratories LimitedNSE · financial results · pdf
Source filing Valiant Laboratories Ltd - 543998 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Intimation Recieved Under Regulation 10(5) Of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Updates - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Press Release - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Valiant Laboratories LimitedNSE · financial results · pdf
Source filing Valiant Laboratories Ltd - 543998 - Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31, 2026.BSE · financial results · pdf
Source filing Valiant Laboratories Ltd - 543998 - Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31, 2026.BSE · financial results · pdf
Source filing Valiant Laboratories Ltd - 543998 - Appointment Of Cost Auditor And Internal AuditorBSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Monitoring Agency ReportBSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31, 2026.BSE · financial results · pdf
Source filing Outcome of Board Meeting - Valiant Laboratories LimitedNSE · financial results · pdf
Source filing Outcome of Board Meeting - Valiant Laboratories LimitedNSE · financial results · pdf
Source filing Outcome of Board Meeting - Valiant Laboratories LimitedNSE · financial results · pdf
Source filing Monitoring Agency Report - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Board Meeting Intimation for Approval Of Financial Results For Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Resignation - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - Valiant Laboratories LimitedNSE · exchange filing · zip
Source filing Valiant Laboratories Ltd - 543998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Closure of Trading WindowBSE · financial results · pdf
Source filing Trading Window - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Valiant Laboratories LimitedNSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Monitoring Agency ReportBSE · exchange filing · pdf
Source filing Valiant Laboratories Ltd - 543998 - Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2025.BSE · financial results · pdf
Source filing